Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

Delayed Quote. Delayed  - 05/03 05:31:08 pm
240.5 CHF   -0.91%
05/03 FOUNDATION MEDI : reports 1Q loss
05/03 ROCHE : FDA Greenlights Zika Blood Center Testing
05/03 ROCHE : highlights personalised medicines and cancer immunotherapies..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
05/03 FOUNDATION MEDICINE : reports 1Q loss
05/03 FOUNDATION MEDICINE, INC. : Results of Operations and Financial Condition, Finan..
05/03 ROCHE : FDA Greenlights Zika Blood Center Testing
05/03 ROCHE : Grapevine
05/03 ROCHE : highlights personalised medicines and cancer immunotherapies at 2016 Ame..
05/03 GENENTECH : Highlights Personalized Medicines and Cancer Immunotherapies at 2016..
05/02 ROCHE : CHMP recommends EU approval of Roche's Gazyvaro for people with previous..
05/02 ROCHE : Glycotope names new chief medical officer
04/29 FOUNDATION MEDICINE : Horizon Blue Cross Blue Shield of New Jerseys Chief Medica..
04/29 ROCHE : CHMP recommends EU approval of Roche’s Gazyvaro for people with pr..
04/29 ROCHE : CHMP recommends EU approval for Roche's Avastin in combination with Tarc..
04/29 ROCHE : Diagnostics Operations Assigned Patent
04/29DJAstraZeneca's Investment Eats Into Profit
04/29 ROCHE : Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer
04/28 Federal Contracts Awarded to Companies in Indiana (April 28)
04/28 Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
04/28DJAbbVie to Buy Cancer-Drug Maker for $5.8 Billion
04/28 ROCHE : MILITARY $3.22 Million Federal Contract Awarded to Roche Diagnostics
04/28DJSanofi Makes $9.3 Billion Bid for U.S. Cancer-Drug Maker
04/27 BIOCON : Delhi High Court permits Biocon, Mylan to carry on trade of Cancer drug..
04/27 BIOCON : Delhi hc strikes down breast cancer biosimilars' approval for roche dru..
04/26 CHUGAI PHARMACEUTICAL : and TWO CELLS Announce a License Agreement for 'gMSC1,' ..
04/25 Mirna Therapeutics Appoints Vincent J. ONeill, M.D., as Chief Medical Officer
04/25 GLAXOSMITHKLINE : Mirna Therapeutics Appoints Vincent J. O'Neill, M.D., as Chief..
04/25 REPORT : Novartis Plans To Sell Its Roche Stake
04/22 CHUGAI PHARMACEUTICAL : Launch of the Agent for Osteoporosis 'Bonviva Tablet 100..
04/22 AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep
04/21 FOUNDATION MEDICINE : Studies in the Area of Gynecologic Cancer Reported from Fo..
04/21 OTSUKA : U.S. Subsidiary Astex Pharmaceuticals Enters Clinical Trial Collaborati..
04/21 ROCHE BEARER SHARE : Nutley board of commissioners' candidates sound off
04/21 ROCHE BEARER SHARE : ASCP Launches Online Toolkit for Diagnosis of Breast Cancer
04/21 ROCHE : Pacific Biosciences of California Announces First Quarter 2016 Financial..
04/21 ROCHE BEARER SHARE : 26.2 Moment that led to the Marathon Scituate native runs t..
04/20 ROCHE BEARER SHARE : Korea appoints new leader
04/19 NOVARTIS : Roche sales set hard challenge for drug industry rivals
04/19DJRoche Revenue Lifted by Cancer and Immunology Drugs -- 2nd Update
04/19DJStocks Grind Out Another Blue-Chip Day
04/19DJRoche Revenue Lifted by Cancer and Immunology Drugs -- Update
04/19DJRoche Revenue Lifted by Cancer and Immunology Drugs
04/19DJRoche Revenue Lifted by Cancer and Immunology Drugs
04/19 ROCHE BEARER SHARE : Korea appoints new leader
04/18 FOUNDATION MEDICINE : Molecular Information Supports Discovery of Precision Ther..
04/12 ROCHE : Genentech : to Present New Data at AAN Showing Superior Efficacy of Inve..
04/12 ROCHE : Genentech : Announces FDA Grants Venclexta™ (venetoclax) Accelerat..
04/11 ROCHE : FDA Grants Priority Review for Genentech’s Cancer Immunotherapy At..
03/30DJROCHE : FDA Allows Zika Test for Blood Donations
03/29 Biosimilar drugs could save up to $110 billion by 2020 - IMS
03/15 ROCHE : FDA Grants Genentech’s Cancer Immunotherapy Atezolizumab Priority ..
03/03 ROCHE HOLDING LTD. : ex-dividend day for annual dividend
03/02DJSwitzerland Fights Uphill Battle Against Strong Franc
03/01 ROCHE : FDA Files Genentech’s Supplemental Biologics License Application o..
02/29 ROCHE : Genentech provides update on two identical phase iii studies of lebrikiz..
02/26 ROCHE : FDA Approves Genentech’s Gazyva® (Obinutuzumab) for Certain People..
02/19 NOVARTIS : wins FDA breakthrough therapy for AML treatment
02/18 BAYER STRATEGY HEAD BAUMANN SET TO B : Manager Magazine
02/17DJRoche's MS Treatment Designated as Breakthrough Therapy
02/17DJRoche Gets Breakthrough Therapy Designation From FDA for Multiple Sclerosis T..
02/17 AstraZeneca wins FDA breakthrough status for key cancer drug
02/03 Seven $1 billion-plus drugs seen reaching market in 2016
01/28 Roche annual profit disappoints, outlook muted
01/28DJRoche Profit Dented by Strong Swiss Franc -- 2nd Update
01/28DJRoche Profit Dented by Strong Swiss Franc -- Update
01/28DJRoche Profit Dented by Strong Swiss Franc
01/28DJROCHE : Profit Dented by Strong Swiss Franc
01/25DJRoche Holding AG Full-year 2015 -- Forecast
01/21DJDrug and Diagnostic Companies Issue Joint Declaration on Antibiotics
01/20DJAbbVie Leukemia Therapy Granted FDA Breakthrough Designation
01/12DJAbbVie, Genentech Leukemia Therapy Granted FDA Priority Review
01/12DJAbbVie, Genentech Leukemia Therapy Granted FDA Priority Review
01/12 ROCHE : Fda grants priority review for venetoclax new drug application
01/11 Drugmaker Shire buys Baxalta for $32 billion after six-month pursuit
01/11 Drugmaker Shire buys Baxalta for $32 billion after six-month pursuit
01/08DJIllumina Files Patent Suit Against Premaitha's Customer in Poland
2015DJStandoff Over Shire's Pursuit of Baxalta Nears an End
2015 GSK gets lift from successful arthritis drug trials
1  2  3  4  5  6  7  8  9  10Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials